mesalamine has been researched along with Multiple Myeloma in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, X | 1 |
| Gu, Y | 1 |
| Cao, XC | 1 |
| Wang, BM | 1 |
| Cao, HL | 1 |
1 other study available for mesalamine and Multiple Myeloma
| Article | Year |
|---|---|
Smoldering Multiple Myeloma Arising in Ulcerative Colitis.
Topics: Aged; Biopsy; C-Reactive Protein; Colitis, Ulcerative; Colonoscopy; gamma-Globulins; Humans; Immunog | 2018 |